FinDogFinDog
Thursday, October 22, 2026Closing data · 4:00 PM ET
English
Log in
FinDog Earnings CheckupEarnings release 10-22 · 10-Q 10-22Data from SEC filings

P&G FY2027 Q1: sales up 4.0%, EPS beats, margin squeeze persists

P&G beat the $1.94 consensus EPS by $0.03 and grew sales 4.0%, yet gross margin fell 160 basis points — the quarter was a volume-and-mix win paid for with cost pressure. Read the scorecard for growth, then the margin lines and the $0.79 per-share cost headwind embedded in guidance, which is where the real story sits.

1 · Expected vs. Actual

Free preview below
EPS (non-GAAP)
Beat
$2.00
Est. $1.94 · +3.1%

Diluted EPS of $1.97 rose 1.0% and cleared the $1.94 consensus by $0.03, while core EPS was $2.00, also up 1.0%. The gap between 4.0% sales growth and 1.0% earnings growth is the whole story: higher commodity and reinvestment costs absorbed the operating leverage. Currency-neutral core EPS was flat versus a year ago.

Revenue
$23.28B
No consensus · YoY +4.0%

Net sales rose 4.0% to $23.28 billion from $22.39 billion, and organic growth was also 4.0%, so currency and deal-making added nothing. Volume contributed 2.4 points and mix 1.1 points, while pricing was barely positive at 0.4 points. That is a demand-led quarter rather than a price-led one, which is the harder kind to repeat.

Members Only

Log in to read 35 analyses a week for free

Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.

Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-10-23

Ask About This Report

Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.

Log in to ask a question.